Beneath the threshold of standard detection, a shadow form of hepatitis B quietly rewires the liver's most fundamental instructions for growth and restraint. Researchers in Beijing have now traced the precise molecular path by which five mutations in the virus's pre-S region overwhelm the cell's natural brakes, activating a signaling cascade that transforms regulated tissue into uncontrolled tumor. In mapping this hidden mechanism, they have also identified two existing drugs capable of interrupting it — a discovery that places precision medicine one step closer to a disease that has long refu